2021
DOI: 10.1016/j.tiv.2021.105137
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
22
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 22 publications
(23 citation statements)
references
References 34 publications
1
22
0
Order By: Relevance
“…As a pre-selection step for testing the docking protocols for the final compounds, we followed the protocols already established in our previous studies. 21,33 In accordance with Fig. 6, the RMSD for the target protein was 0.4 Å, signifying that the docking protocol was both reliable and ready for subsequent comparative studies (Table 4).…”
Section: Resultssupporting
confidence: 74%
See 3 more Smart Citations
“…As a pre-selection step for testing the docking protocols for the final compounds, we followed the protocols already established in our previous studies. 21,33 In accordance with Fig. 6, the RMSD for the target protein was 0.4 Å, signifying that the docking protocol was both reliable and ready for subsequent comparative studies (Table 4).…”
Section: Resultssupporting
confidence: 74%
“…21 It also possesses a conserved active site and lacks apparent homologs in mammals. 28 A few reports mentioned above 21,26 also suggested the mode of action of antimycobacterial imidazopyridines through inhibition of InhA of MTB. Hence, based on the reported rationale, targeting the InhA enzyme followed by disruption of mycobacterial cellular homeostasis may be the most appropriate strategy for the current molecular docking study, and hence we docked our compounds at the active site of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis (PDB 4TZK).…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“… 58 Compounds with activity >90% of inhibition of the growth of MT in MABA were further tested against M. abscessus ATCC 19977, M. chelonae ATCC 35752, M. marinum ATCC 927, M. avium ATCC 15769, and M. kansasii ATCC 12478, using MABA 58 and a cytotoxicity assay against Vero cell line ATCC CCL-81. 60 For the latter, 0.6 mM of resazurin was used and the absorbance was recorded at 530 nm (excitation) and 590 nm (emission). Positive controls for all assays are indicated in Tables 3 and 4 .…”
Section: Methodsmentioning
confidence: 99%